The next generation of antimicrobial peptides (AMPs) as molecular therapeutic tools for the treatment of diseases with social and economic impacts

Drug Discov Today. 2017 Feb;22(2):234-248. doi: 10.1016/j.drudis.2016.10.017. Epub 2016 Nov 23.


Anti-infective drugs have had a key role in the contemporary world, contributing to dramatically decrease mortality rates caused by infectious diseases worldwide. Antimicrobial peptides (AMPs) are multifunctional effectors of the innate immune system of mucosal surfaces and present antimicrobial activity against a range of pathogenic viruses, bacteria, and fungi. However, the discovery and development of new antibacterial drugs is a crucial step to overcome the great challenge posed by the emergence of antibiotic resistance. In this review, we outline recent advances in the development of novel AMPs with improved antimicrobial activities that were achieved through characteristic structural design. In addition, we describe recent progress made to overcome some of the major limitations that have hindered peptide biosynthesis.

Publication types

  • Review

MeSH terms

  • Animals
  • Anti-Bacterial Agents / biosynthesis*
  • Anti-Bacterial Agents / chemistry
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • CRISPR-Cas Systems
  • Drug Design
  • Drug Resistance, Bacterial
  • Drug Resistance, Multiple
  • Drug Therapy
  • Economics
  • Gene Editing
  • Humans
  • Peptide Biosynthesis
  • Peptides* / chemistry
  • Peptides* / metabolism
  • Peptides* / pharmacology
  • Peptides* / therapeutic use
  • Social Change
  • Tobacco / metabolism


  • Anti-Bacterial Agents
  • Peptides